Fostering responsible research with CRISPR-Cas9 - Paris

On March the 16th, 2016, Inserm Ethics Committee organized a workshop in Paris, on the ethical and societal aspects of the development of the new genome editing technologies.

This meeting organized by the Ethics Committee of Inserm follows on the response to a referral from the CEO of Inserm questioning the ethical and societal aspects of the development of the new genome editing technologies used in the laboratories of the Institute. The purpose of this one-day meeting was to find the expression of a European approach to the development of these technologies.

The experts invited have tried to define an ethical framework allowing scientists to develop these new technologies shielded from the controversy generated around the development of GMOs and nanotechnologies. Through these exchanges with european senior experts, the Ethics Committee of Inserm also hopes to have contributed to the advancement of a responsible scientific research.

With the participation of:

  • Bernard Baertschi
  • Hervé Chneiweiss
  • Christiane Druml
  • Marie Filipa Ferraz-De-Oliveira
  • Bärbel Friedrich
  • Carine Giovannangeli
  • Pierre Jouannet
  • Dirk Lanzerath
  • Anne-Sophie Lapointe
  • Yves Lévy
  • Katherine Littler
  • Jennifer Merchant
  • Peter Mills
  • Agnès Saint-Raymond